301 related articles for article (PubMed ID: 15149845)
21. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model.
Garwicz D; Lennartsson A; Jacobsen SE; Gullberg U; Lindmark A
Haematologica; 2005 Jan; 90(1):38-44. PubMed ID: 15642667
[TBL] [Abstract][Full Text] [Related]
22. Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis.
Lundberg E; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1991 Feb; 51(1):23-9. PubMed ID: 1708522
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium.
Hiemstra PS; van Wetering S; Stolk J
Eur Respir J; 1998 Nov; 12(5):1200-8. PubMed ID: 9864022
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
25. Alpha-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase.
Manna SK; Sarkar A; Sreenivasan Y
Eur J Immunol; 2006 Mar; 36(3):754-69. PubMed ID: 16479540
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of neutrophil elastase by the alpha1-proteinase inhibitor-immunoglobulin A complex.
Adam C; Bieth JG
FEBS Lett; 1996 May; 385(3):201-4. PubMed ID: 8647251
[TBL] [Abstract][Full Text] [Related]
27. Elastolysis by proteinase 3 and its inhibition by alpha(1)-proteinase inhibitor: a mechanism for the incomplete inhibition of ongoing elastolysis.
Ying QL; Simon SR
Am J Respir Cell Mol Biol; 2002 Mar; 26(3):356-61. PubMed ID: 11867344
[TBL] [Abstract][Full Text] [Related]
28. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
29. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
Renesto P; Chignard M
J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
[TBL] [Abstract][Full Text] [Related]
30. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor.
Duranton J; Adam C; Bieth JG
Biochemistry; 1998 Aug; 37(32):11239-45. PubMed ID: 9698370
[TBL] [Abstract][Full Text] [Related]
31. German cockroach frass proteases cleave pro-matrix metalloproteinase-9.
Hughes VS; Page K
Exp Lung Res; 2007; 33(3-4):135-50. PubMed ID: 17558676
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo.
Duranton J; Bieth JG
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):57-61. PubMed ID: 12600819
[TBL] [Abstract][Full Text] [Related]
33. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases.
Ramaha A; Patston PA
Arch Biochem Biophys; 2002 Jan; 397(1):77-83. PubMed ID: 11747312
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
Owen CA; Campbell EJ
J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
[TBL] [Abstract][Full Text] [Related]
35. Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates.
Attucci S; Korkmaz B; Juliano L; Hazouard E; Girardin C; Brillard-Bourdet M; Réhault S; Anthonioz P; Gauthier F
Biochem J; 2002 Sep; 366(Pt 3):965-70. PubMed ID: 12088507
[TBL] [Abstract][Full Text] [Related]
36. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
37. (-)Epigallocatechin-3-gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema, and invasion.
Sartor L; Pezzato E; Garbisa S
J Leukoc Biol; 2002 Jan; 71(1):73-9. PubMed ID: 11781382
[TBL] [Abstract][Full Text] [Related]
38. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of ovalbumin-induced pulmonary eosinophilia by intranasal administration of alpha1-proteinase inhibitor type 2 antisense oligonucleotides.
Sung HN; Jeon CH; Gill BC; Kim HR; Cheong SW; Park JH
Immunol Lett; 2009 Jan; 122(1):76-83. PubMed ID: 19111575
[TBL] [Abstract][Full Text] [Related]
40. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
Hansen G; Hoffjan S; Mosler K; Schuster A
Lung; 2001; 179(3):185-94. PubMed ID: 11891608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
